Literature DB >> 10553987

FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation.

A D Sperfeld1, M B Collatz, H Baier, M Palmbach, A Storch, J Schwarz, K Tatsch, S Reske, M Joosse, P Heutink, A C Ludolph.   

Abstract

Recently, mutations in the tau gene on chromosome 17 were found causative for autosomal dominantly inherited frontotemporal dementia and parkinsonism (FTDP-17). We describe a family carrying a missense mutation at nucleotide 1137 C --> T, resulting in the amino acid substitution P301S. Methods of investigations include clinical, electrophysiological, and imaging techniques. This kindred presents with a novel phenotype characterized by an early onset of rapidly progressive frontotemporal dementia and parkinsonism in combination with epileptic seizures. We define the dopaminergic deficits as being predominantly presynaptic by the use of single-photon emission computed tomography with a dopamine transporter ligand. The association of this early-onset phenotype with P301S mutation is not entirely consistent with current criteria for the diagnosis of frontotemporal dementias and may encourage the search for tau mutations in diseases similar but not identical to FTDP-17. Also, the change from proline to serine suggests that this mutation might contribute to tau hyperphosphorylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553987     DOI: 10.1002/1531-8249(199911)46:5<708::aid-ana5>3.0.co;2-k

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  51 in total

Review 1.  Frontotemporal dementia and tauopathy.

Authors:  Y Yoshiyama; V M Lee; J Q Trojanowski
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

2.  Novel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia.

Authors:  Manuela Neumann; Silvia Diekmann; Uwe Bertsch; Ben Vanmassenhove; Bernhard Bogerts; Hans A Kretzschmar
Journal:  Neurogenetics       Date:  2005-03-12       Impact factor: 2.660

3.  Familial autosomal dominant cortico-basal degeneration with the P301S mutation in the tau gene: an example of phenotype variability.

Authors:  W Casseron; J P Azulay; E Guedj; J L Gastaut; J Pouget
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

4.  Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.

Authors:  Katharina Schindowski; Alexis Bretteville; Karelle Leroy; Séverine Bégard; Jean-Pierre Brion; Malika Hamdane; Luc Buée
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 5.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

6.  Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.

Authors:  Hiroki Takeuchi; Keiko Imamura; Bin Ji; Kayoko Tsukita; Takako Enami; Keizo Takao; Tsuyoshi Miyakawa; Masato Hasegawa; Naruhiko Sahara; Nobuhisa Iwata; Makoto Inoue; Hideo Hara; Takeshi Tabira; Maiko Ono; John Q Trojanowski; Virginia M-Y Lee; Ryosuke Takahashi; Tetsuya Suhara; Makoto Higuchi; Haruhisa Inoue
Journal:  NPJ Vaccines       Date:  2020-03-25       Impact factor: 7.344

7.  SIRT1: A Novel Way to Target Tau?

Authors:  Hunter S Futch; Cara L Croft
Journal:  J Neurosci       Date:  2018-09-05       Impact factor: 6.167

8.  Proteopathic tau seeding predicts tauopathy in vivo.

Authors:  Brandon B Holmes; Jennifer L Furman; Thomas E Mahan; Tritia R Yamasaki; Hilda Mirbaha; William C Eades; Larisa Belaygorod; Nigel J Cairns; David M Holtzman; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-26       Impact factor: 11.205

9.  Tau mutants bind tubulin heterodimers with enhanced affinity.

Authors:  Shana Elbaum-Garfinkle; Garrett Cobb; Jocelyn T Compton; Xiao-Han Li; Elizabeth Rhoades
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

Review 10.  Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Authors:  Jianhua Zhou; Qingming Yu; Tie Zou
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.